Results for tag: "Immunostimulatory Adjuvant"

The Immunostimulatory Adjuvant market is a subset of the Immune Disorders Drugs market. It is composed of products that are used to enhance the body's immune response to a particular antigen. These products are used to treat a variety of immune-related diseases, such as allergies, autoimmune diseases, and cancer. Immunostimulatory adjuvants are typically administered in combination with other drugs, such as vaccines, to increase the effectiveness of the treatment. Immunostimulatory adjuvants are typically composed of a combination of components, such as cytokines, Toll-like receptor agonists, and other immunomodulators. These components are designed to activate the body's immune system and increase the production of antibodies. The Immunostimulatory Adjuvant market is highly competitive, with many companies offering products for the treatment of immune-related diseases. Some of the major players in the market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Novartis. Show Less Read more